CME/CE - PACE-CME

113-128 of 155

MinuteCE®
Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes
Gianluigi Savarese, MD, PhD, FESC, FHFA; James Burton, DM, FRCP
0.75 credits 3 episodes
- Gianluigi Savarese, MD, PhD, FESC, FHFA
- James Burton, DM, FRCP
- Aaron Wong, MD
0.75 credits 3 episodes
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
Julia Brandts, MD
0.75 program credits
- Julia Brandts, MD
0.75 program credits
The remaining challenges in lowering LDL-c in patients at increased CV risk
The remaining challenges in lowering LDL-c in patients at increased CV risk
MinuteCE®
The remaining challenges in lowering LDL-c in patients at increased CV risk
Prof. Kausik Ray
0.75 program credits
- Prof. Kausik Ray
0.75 program credits
MinuteCE®
Clinical choices in managing LDL-c: Where do novel therapies fit in?
Kausik Ray, MBChB, MD, MPhil; Julia Brandts, MD
0.75 credits 4 episodes
- Kausik Ray, MBChB, MD, MPhil
- Julia Brandts, MD
- Pasquale Perrone-Filardi, MD, PhD
- Ulrich Laufs, MD, PhD
0.75 credits 4 episodes
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
MinuteCE®
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
James Burton, DM, FRCP; Aaron Wong, MD
0.75 program credits
- James Burton, DM, FRCP
- Aaron Wong, MD
0.75 program credits
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Carolyn Lam, MD, PhD; Scott Solomon, MD
0.50 credits
- Carolyn Lam, MD, PhD
- Scott Solomon, MD
- Mikhail Kosiborod, MD
0.50 credits
CETP inhibition: Lessons from two decades of clinical trials
CETP inhibition: Lessons from two decades of clinical trials
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
Stephen Nicholls, FRACP, FACC, FESC, FAHA
0.50 program credits
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
0.50 program credits
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
0.50 program credits
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
0.50 program credits
MinuteCE®
Innovating the clinical management of LDL-c: Exploring CETP as therapeutic target
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma; Stephen Nicholls, FRACP, FACC, FESC, FAHA
0.50 credits 3 episodes
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
- Erin Michos
0.50 credits 3 episodes
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
MinuteCE®
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
Erin Michos
0.50 program credits
- Erin Michos
0.50 program credits
What are the challenges in making the right diagnosis in HCM?
What are the challenges in making the right diagnosis in HCM?
MinuteCE®
What are the challenges in making the right diagnosis in HCM?
Perry Elliott, MD
0.75 program credits
- Perry Elliott, MD
0.75 program credits
Understanding the etiology of HCM and pathways for intervention
Understanding the etiology of HCM and pathways for intervention
MinuteCE®
Understanding the etiology of HCM and pathways for intervention
Roberto Barriales-Villa, MD, PhD
0.75 program credits
- Roberto Barriales-Villa, MD, PhD
0.75 program credits
MinuteCE®
Managing hypertrophic cardiomyopathy in clinical practice: The patient journey
Perry Elliott, MD; Roberto Barriales-Villa, MD, PhD
0.75 credits 3 episodes
- Perry Elliott, MD
- Roberto Barriales-Villa, MD, PhD
- Iacopo Olivotto, MD
0.75 credits 3 episodes
Updates From the 7th World Symposium Task Force
Updates From the 7th World Symposium Task Force
CME/CE
Updates From the 7th World Symposium Task Force
Eric D. Austin, MD, MSCI; Hilary M. DuBrock, MD
1.00 credit
- Eric D. Austin, MD, MSCI
- Hilary M. DuBrock, MD
- H. James Ford, MD
- Gustavo A. Heresi, MD, MS
- Gergely Meszaros, JD, MSc
- Oksana A. Shlobin, MD
- Ioana Preston, MD
- Lucilla Piccari, MD, PhD
1.00 credit
The clinical challenge of managing a patient with HCM
The clinical challenge of managing a patient with HCM
MinuteCE®
The clinical challenge of managing a patient with HCM
Iacopo Olivotto, MD
0.75 program credits
- Iacopo Olivotto, MD
0.75 program credits
Comprehensive Management of Individuals with CKM Syndrome
Comprehensive Management of Individuals with CKM Syndrome
MinuteCE®
Comprehensive Management of Individuals with CKM Syndrome
Muthiah Vaduganathan, MD
1.00 program credit
- Muthiah Vaduganathan, MD
1.00 program credit

8/8